These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9883247)

  • 1. Cutaneous leishmaniasis on an unusual site--the glans penis.
    Grunwald MH; Amichai B; Trau H
    Br J Urol; 1998 Dec; 82(6):928. PubMed ID: 9883247
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
    Arana BA; Mendoza CE; Rizzo NR; Kroeger A
    Am J Trop Med Hyg; 2001 Nov; 65(5):466-70. PubMed ID: 11716099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
    Schallreuter KU; Lemke KR
    Hautarzt; 1994 Nov; 45(11):783-6. PubMed ID: 7822205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.
    el-On J; Weinrauch L; Livshin R; Even-Paz Z; Jacobs GP
    Br Med J (Clin Res Ed); 1985 Sep; 291(6497):704-5. PubMed ID: 3929905
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
    Soto J; Hernandez N; Mejia H; Grogl M; Berman J
    Clin Infect Dis; 1995 Jan; 20(1):47-51. PubMed ID: 7727669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
    Soto J; Fuya P; Herrera R; Berman J
    Clin Infect Dis; 1998 Jan; 26(1):56-8. PubMed ID: 9455509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of giant hyperkeratotic cutaneous leishmaniasis in the penis.
    Gülüm M; Yeşilova Y; Savaş M; Çiftçi H; Yeni E; Zeyrek FY
    Turkiye Parazitol Derg; 2013; 37(1):53-4. PubMed ID: 23619048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcerative penile leishmaniasis in a child.
    Yesilova Y; Turan E; Sürücü HA; Kocarslan S; Tanrikulu O; Eroglu N
    Indian J Dermatol Venereol Leprol; 2014; 80(3):247-9. PubMed ID: 24823403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.
    Krause G; Kroeger A
    Trans R Soc Trop Med Hyg; 1994; 88(1):92-4. PubMed ID: 8154018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy.
    El-On J; Witztum A; Schnur LF
    Infect Immun; 1986 Feb; 51(2):704-6. PubMed ID: 3943909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycin.
    Carter KC; Alexander J; Baillie AJ
    Ann Trop Med Parasitol; 1989 Jun; 83(3):233-9. PubMed ID: 2604461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX; Weigel MM; Calvopiña M; Mancheno M; Rodriguez R
    Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
    Krause G; Kroeger A
    Clin Infect Dis; 1999 Aug; 29(2):466-7. PubMed ID: 10476776
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z; Nakhli A; Rassaii S
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
    Weinrauch L; Cawich F; Craig P; Sosa JX; el-On J
    J Am Acad Dermatol; 1993 Sep; 29(3):443-6. PubMed ID: 8349861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical treatment of cutaneous leishmaniasis.
    El-On J; Livshin R; Even-Paz Z; Hamburger D; Weinrauch L
    J Invest Dermatol; 1986 Aug; 87(2):284-8. PubMed ID: 3734476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.
    el-On J; Sneier R; Elias E
    Isr J Med Sci; 1992 Dec; 28(12):847-51. PubMed ID: 1286954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
    el-On J; Halevy S; Grunwald MH; Weinrauch L
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):227-31. PubMed ID: 1430361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occlusive paromomycin for cutaneous leishmaniasis.
    Bryceson AD
    Lancet; 1997 May; 349(9063):1477. PubMed ID: 9164342
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.
    Asilian A; Jalayer T; Whitworth JA; Ghasemi RL; Nilforooshzadeh M; Olliaro P
    Am J Trop Med Hyg; 1995 Dec; 53(6):648-51. PubMed ID: 8561269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.